angiotensin ii has been researched along with Lower Urinary Tract Symptom in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A Faria, J; Anhê, GF; Antunes, E; Calmasini, FB; Gontijo, JA; Mónica, FZ; Muscará, MN; Ramos-Filho, AC; Teixeira, SA; Zanesco, A | 1 |
| Boudjeltia, KZ; Delporte, C; Franck, T; Moguilevsky, N; Raes, M; Roumeguère, T; Serteyn, D; Van Antwerpen, P; Van Meerhaeghe, A; Vanhaeverbeek, M; Vanhamme, L | 1 |
2 other study(ies) available for angiotensin ii and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
The renin-angiotensin system plays a major role in voiding dysfunction of ovariectomized rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carbachol; Dose-Response Relationship, Drug; Estradiol; Female; In Vitro Techniques; Losartan; Lower Urinary Tract Symptoms; Ovariectomy; Peptidyl-Dipeptidase A; Phenylephrine; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Urethra; Urinary Bladder; Urination; Vasoconstrictor Agents | 2013 |
Myeloperoxidase-dependent LDL modifications in bloodstream are mainly predicted by angiotensin II, adiponectin, and myeloperoxidase activity: a cross-sectional study in men.
Topics: Adiponectin; Adult; Aged; Angiotensin II; Apolipoproteins B; Cross-Sectional Studies; Humans; Lipoproteins, LDL; Lower Urinary Tract Symptoms; Male; Middle Aged; NADPH Oxidases; Peroxidase; Peroxidases | 2013 |